Media Room
Second quarter 2024 results
Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on July 25th, 2024. The presentation will be followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EST)
Press releases
June 28, 2024
Media Update: Frexalimab new phase 2 data showed reduction of key biomarker of nerve cell damage in relapsing MS
June 26, 2024
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
June 25, 2024
Media Update: Riliprubart one-year follow-up from phase 2 study underpin the potential as a first-in-class treatment in chronic inflammatory demyelinating polyneuropathy
Contact our media team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
For any other request, please call the switchboard: +33 1 53 77 40 00
Publications
Declaration of extra-financial performance 2023 (ESG Report)
Half Year 2023 Financial Report XBRL Package
Half Year 2023 Financial Report
First quarter 2023 results